Best R, Barwick B, Best A, Berger N, Harrison C, Wright M
Sports (Basel). 2018; 6(4).
PMID: 30287789
PMC: 6316849.
DOI: 10.3390/sports6040111.
Liu H, Zhou Y, Tang L
Mol Med Rep. 2017; 16(3):2445-2454.
PMID: 28677810
PMC: 5547974.
DOI: 10.3892/mmr.2017.6894.
Varma S, Kovtun S
Mol Vis. 2013; 19:493-500.
PMID: 23441122
PMC: 3580991.
Brezinova V
Br J Clin Pharmacol. 2012; 1(3):203-8.
PMID: 22454948
PMC: 1402564.
DOI: 10.1111/j.1365-2125.1974.tb00237.x.
Rihs M, Muller C, Baumann P
Eur Arch Psychiatry Clin Neurosci. 1996; 246(2):83-92.
PMID: 9063913
DOI: 10.1007/BF02274898.
Caffeine and nicotine improve visual tracking by rats: a comparison with amphetamine, cocaine and apomorphine.
Evenden J, Turpin M, Oliver L, Jennings C
Psychopharmacology (Berl). 1993; 110(1-2):169-76.
PMID: 7870879
DOI: 10.1007/BF02246968.
Effects of caffeine or diphenhydramine on visual vigilance.
Fine B, KOBRICK J, Lieberman H, MARLOWE B, Riley R, Tharion W
Psychopharmacology (Berl). 1994; 114(2):233-8.
PMID: 7838913
DOI: 10.1007/BF02244842.
Biphasic effect of methylxanthines on acetylcholine release from electrically-stimulated brain slices.
Pedata F, Pepeu G, Spignoli G
Br J Pharmacol. 1984; 83(1):69-73.
PMID: 6487897
PMC: 1987183.
DOI: 10.1111/j.1476-5381.1984.tb10120.x.
Effects of caffeine on hippocampal pyramidal cells in vitro.
Greene R, Haas H, Hermann A
Br J Pharmacol. 1985; 85(1):163-9.
PMID: 4027463
PMC: 1916777.
DOI: 10.1111/j.1476-5381.1985.tb08843.x.
Caffeine and endurance performance.
Powers S, Dodd S
Sports Med. 1985; 2(3):165-74.
PMID: 3892626
DOI: 10.2165/00007256-198502030-00002.
States of anxiety and their induction by drugs.
Lader M, Bruce M
Br J Clin Pharmacol. 1986; 22(3):251-61.
PMID: 3533122
PMC: 1401129.
DOI: 10.1111/j.1365-2125.1986.tb02884.x.
Neurobehavioural effects of occupational exposure to organic solvents among construction painters.
Fidler A, Baker E, Letz R
Br J Ind Med. 1987; 44(5):292-308.
PMID: 3496112
PMC: 1007827.
DOI: 10.1136/oem.44.5.292.
Discriminative stimulus effects of caffeine and benzphetamine in amphetamine-trained volunteers.
Chait L, Johanson C
Psychopharmacology (Berl). 1988; 96(3):302-8.
PMID: 3146764
DOI: 10.1007/BF00216054.
Caffeine physical dependence: a review of human and laboratory animal studies.
Griffiths R, Woodson P
Psychopharmacology (Berl). 1988; 94(4):437-51.
PMID: 3131789
DOI: 10.1007/BF00212836.
The effects of low doses of caffeine on human performance and mood.
Lieberman H, Wurtman R, Emde G, Roberts C, Coviella I
Psychopharmacology (Berl). 1987; 92(3):308-12.
PMID: 3114783
DOI: 10.1007/BF00210835.
Acute autonomic nervous system effects of caffeine in prepubertal boys.
ZAHN T, Rapoport J
Psychopharmacology (Berl). 1987; 91(1):40-4.
PMID: 3103158
DOI: 10.1007/BF00690924.
Reinforcing and subjective effects of caffeine in normal human volunteers.
Stern K, Chait L, Johanson C
Psychopharmacology (Berl). 1989; 98(1):81-8.
PMID: 2498963
DOI: 10.1007/BF00442010.
Effects of caffeine, time of day and user history on study-related performance.
Mitchell P, Redman J
Psychopharmacology (Berl). 1992; 109(1-2):121-6.
PMID: 1365645
DOI: 10.1007/BF02245489.
Effects of caffeine and cyclizine alone and in combination on human performance, subjective effects and EEG activity.
Clubley M, Bye C, HENSON T, Peck A, Riddington C
Br J Clin Pharmacol. 1979; 7(2):U57-63.
PMID: 367411
PMC: 1429440.
DOI: 10.1111/j.1365-2125.1979.tb00912.x.
